Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
791.50    1.50 (0.19%)
Bid:
792.00
Ask:
795.00
Spread: 3.00 (0.379%)
Market Cap: £911.60m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

16 Apr 2018 07:25

RNS Number : 9326K
Kainos Group plc
16 April 2018
 

16 April 2018

 

Kainos Group plc

("Kainos" or "the Company")

Trading Update

 

Kainos Group plc, a leading provider of Digital Services and Platforms, today issues a trading update for the year ended 31 March 2018. Trading in the period has continued in line with market expectations and the Company remains well positioned in its core markets.

Growth in Digital Services has been particularly strong, driven by both Digital Transformation and Workday, and with continued momentum across government and healthcare clients. Our international client base has also continued to expand, supported by the Group's broadened European footprint and growing reputation in the commercial sector following sales investment. A very strong sales performance has generated a comparable increase in contracted backlog.

Digital Platforms has performed in line with expectations, mainly driven by the Kainos Smart platform, where we have continued to acquire new clients successfully. The constrained funding in the UK NHS continues to impact short term growth of the Kainos Evolve platforms, although sales activity levels are showing signs of improvement that are consistent with our expectations.

Kainos has a robust balance sheet with no debt and strong cash generation. The Company has a growing level of recurring revenue and has a solid pipeline.

Recruitment remains strong, with over 194 people joining Kainos since 1 April 2017, bringing the total number of employees and contractors worldwide to 1,169 at the end of March 2018.

Kainos will announce results for the year ended 31 March 2018 on Tuesday 29 May 2018.

 

- ENDS-

For further information, please contact:

Kainos

via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Peter McKeown, Deputy Chief Financial Officer

Investec Bank plc 

+44 20 7597 4000

Patrick Robb / Sebastian Lawrence

Canaccord Genuity

+44 20 7523 4606

Simon Bridges / Emma Gabriel

FTI Consulting LLP

+44 20 3727 1000

Matt Dixon / Harry Staight

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the largest boutique partner for Workday Inc. ('Workday') in Europe, responsible for implementing Workday's innovative Software- as-a-Service (SaaS) platform for enterprise customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos employs approximately 1,200 staff and contractors across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms businesses.

Kainos is listed on the London Stock Exchange (KNOS). For further information, please visit www.kainos.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIJMATMBIBBJP
Date   Source Headline
1st Aug 20234:02 pmRNSHolding(s) in Company
1st Aug 20233:58 pmRNSTotal Voting Rights
21st Jul 20235:11 pmRNSAnnual Report 2023
3rd Jul 20231:20 pmRNSTotal Voting Rights
3rd Jul 20237:00 amRNSAcquisition of RapidIT-Cloudbera, Inc.
23rd Jun 202312:55 pmRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSPlanned CEO Transition
1st Jun 202311:23 amRNSTotal Voting Rights
23rd May 20234:36 pmRNSHolding(s) in Company
22nd May 20237:00 amRNSFinal Results
3rd May 20235:21 pmRNSHolding(s) in Company
2nd May 20237:00 amRNSAppointment of Independent Non-Executive Director
19th Apr 20237:00 amRNSTrading Statement
3rd Apr 20232:30 pmRNSTotal Voting Rights
17th Mar 20235:05 pmRNSHolding(s) in Company
1st Mar 202312:07 pmRNSTotal Voting Rights
1st Feb 20239:35 amRNSTotal Voting Rights
30th Dec 20229:53 amRNSTotal Voting Rights
29th Dec 202210:20 amRNSHolding(s) in Company
21st Dec 20224:58 pmRNSHolding(s) in Company
20th Dec 20224:15 pmRNSDirector/PDMR Shareholding
7th Dec 20228:40 amRNSHolding(s) in Company
1st Dec 202212:10 pmRNSTotal Voting Rights
18th Nov 20224:38 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSHalf-year Report
18th Oct 20227:00 amRNSUpdate on office development & partial site sale
3rd Oct 202211:14 amRNSTotal Voting Rights
28th Sep 20222:04 pmRNSResult of AGM
1st Sep 20222:05 pmRNSTotal Voting Rights
1st Sep 20227:00 amRNSTrading Statement
24th Aug 20222:07 pmRNSNotice of AGM
1st Aug 202211:12 amRNSTotal Voting Rights
29th Jul 202210:12 amRNSPublication of Annual Report 2022
29th Jul 20227:00 amRNSWorkday Partner Status Update
1st Jul 20225:36 pmRNSDirector Share Awards
29th Jun 202210:15 amRNSDirector/PDMR Shareholding
20th Jun 20225:22 pmRNSHolding(s) in Company
1st Jun 202211:42 amRNSTotal Voting Rights
23rd May 20227:00 amRNSFull Year Results
4th May 202210:56 amRNSTotal Voting Rights
19th Apr 20227:00 amRNSTrading Statement
31st Mar 20222:33 pmRNSTotal Voting Rights
1st Mar 20221:21 pmRNSTotal Voting Rights
21st Feb 20227:00 amRNSPlanalyse acquisition strengthens Kainos
1st Feb 202212:40 pmRNSTotal Voting Rights
11th Jan 20227:00 amRNSKainos acquires Blackline Group
10th Jan 20224:14 pmRNSDirector/PDMR Shareholding
31st Dec 202110:26 amRNSTotal Voting Rights
13th Dec 20213:26 pmRNSDirector/PDMR Shareholding
2nd Dec 20213:23 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.